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ABSTRACT
Databases of mutations causing Mendelian disease play a
crucial role in research, diagnostic and genetic health care
and can play a role in life and death decisions. These
databases are thus heavily used, but only gene or locus
specific databases have been previously reviewed for
completeness, accuracy, currency and utility. We have
performed a review of the various general mutation
databases that derive their data from the published
literature and locus specific databases. Only two—the
Human Gene Mutation Database (HGMD) and Online
Mendelian Inheritance in Man (OMIM)—had useful
numbers of mutations. Comparison of a number of
characteristics of these databases indicated substantial
inconsistencies between the two databases that included
absent genes and missing mutations. This situation
strengthens the case for gene specific curation of
mutations and the need for an overall plan for collection,
curation, storage and release of mutation data.
The collection of lists of mutations causing single
gene disorders began when the definition of globin
gene mutations at the protein level became
possible.1 It was then that Victor McKusick began
collecting a compendium of inherited syndromes
under the title Mendelian Inheritance in Man
(MIM).2 After the advent of DNA sequencing, the
rate of discovery of mutations accelerated and
MIM began adding mutations to the compendium
as they were characterised. Around the same time,
David Cooper began specifically collecting genetic
mutations to analyse their nature and frequency in
order to find the most common sequence changes
in humans.3 Databases of this type are referred to
as general or central mutation databases (see Box 1
for definitions) and today these two are available
online as Online Mendelian Inheritance in Man
(OMIM)4–6 and the Human Gene Mutation
Database (HGMD),7 respectively. These and a
number of newer general mutation databases
reviewed in this study are summarised in table 1.
Although official usage statistics are not readily
accessible on the websites, the information stored
in these databases is extremely important and
widely used. These databases are particularly
useful for those dealing in mutations found in
patients as the first questions asked are, ‘‘Is this
sequence variation pathogenic?’’ and, ‘‘Has it been
found before?’’ If others have seen such a change
and have reported investigations showing it to be
pathogenic, this makes the work of the enquiring
laboratory or clinicians easier and more cost
effective. Among many other uses,9 those studying
the function of genes and their products are using
the experiments of nature to define essential base
or amino acid changes. Besides defining the actual
mutations and indicating their source, general
databases list other properties of the mutation
and the patient concerned. Further, other features
such as mutation maps and links, etc, may be
included.
In contrast to general mutation databases,
databases of mutations in individual genes (Locus
Specific Databases, LSDBs) have been developed,
beginning with the globin mutations.10 These
databases are a rich source of information on the
gene itself and its mutations, and have been
referred to as knowledge bases.11–13 A recent survey
indicated some 678 genes have databases14 that are
curated by experts in each gene. In a 2002 review
Claustres et al compared 80 data fields occurring
over a sample of 100 representative databases.15
This review was based in part on earlier recom-
mendations of ideal database content which
produced an entry form for submitting variants
to such a database (http://www.hgvs.org/entry.
html).12 13
Because of the need for a rapid and complete
access to mutation data we have reviewed a
number of GMDBs to assess their content,
currency and completeness.
METHODS
Comparison of all GMDBs in relation to a number of
features
Seven GMDBs containing or providing access to
mutations were listed (table 1) and compared
according to the relevant criteria used by Claustres
et al15 (see supplementary table 1, available online).
Four other databases were included as controls or
comparisons. These included the SNP databases:
HGVbase16 and dbSNP;17 and two LSDBs: PAH18
and Fanconi Anaemia. Characteristics were
assessed by one operator in October 2006.
Comparison of the main GMDBs containing
mutations: OMIM and HGMD
All genes and their variations listed in OMIM were
taken from the omim.txt and mim2gene down-
loadable files (ftp.ncbi.nih.gov; downloaded on 10
October 2006). By text-mining the omim.txt file
we were able to group each variation into ‘‘inser-
tion’’; ‘‘deletion’’; ‘‘mutation’’ (including those
occurring in exons, introns and regulatory regions);
and ‘‘other’’ categories. Programs written for text
mining were developed in Perl5 and will be made
available upon request.
We compared the variations in the ‘‘mutation’’
category extracted from OMIM to those in the
HGMD commercial release (version 6.3, 30
September 2006). Mutation data held in HGMD
were collected by querying the Missense/nonsense,
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Splicing and Regulatory tables only in the HGMD database.
The nomenclature for many genes is often derived from
individual researchers, resulting in many aliases for a single
gene. To ensure that we compared like with like, genes in both
OMIM and HGMD were converted to their Human Genome
Organisation (HUGO) Nomenclature Committee (HGNC)
approved gene name.19 This was achieved by first converting
each alias gene name to their unique ENTREZ identifier, by
querying the NCBI text files: gene_info and gene_history.
ENTREZ identifiers were then converted to their corresponding
HGNC gene name, again using the NCBI files. For genes that
have not yet been allocated a HGNC name, the ENTREZ gene
name was retained.
Currency of data in HGMD in relation to mutations in the
literature
Issues of Human Mutation, starting with those that coincide
with the most recent HGMD public release, were reviewed to
determine the currency of information in HGMD. Three
different novel mutations reported in each issue (see supple-
mentary tables 1 and 2, available online) were randomly
selected and then searched for in HGMD. This process was
undertaken on three separate occasions for the public version of
HGMD: May 2004, May 2005 and January 2007. In January
2007 the same mutations were also assessed in the commercial
release of HGMD (version 6.4, 15 December 2006).
Search for specific mutations in HOWDY, GeneCards, EBI,
Mutation Discovery and GDB
Two specific mutations were taken from the literature and
searched for in the databases other than OMIM, HGMD and
their LSDBs. These were a PAH mutation p.R158Q20 and PKD2
p.Q405X.21 The presence or absence of each mutation was
recorded.
Number of mutations in GMDBs compared with the number in
LSDBs
Four LSDBs of varying size were randomly selected and the
number of mutations and polymorphisms found in each were
recorded. These were then compared against mutation entries
found in GMDBs, including the HGMD public release.
RESULTS
Comparison of all GMDBs in relation to a number of features
Of the general databases checked against our 68 criteria (see
supplementary table 1, available online) those that display
mutations are: GDB, HGMD, OMIM and Mutation Discovery
(although some polymorphisms are included as well in these
databases). Those displaying both mutations and SNPs are: EBI,
GeneCards and HOWDY, and those displaying SNPs alone,
which we studied for comparative purposes, are HGVbase and
dbSNP (although dbSNP does include a limited number of
mutations).
Box 1: Definitions (Cotton and Scriver 1998)8
c Mutation: Base changes shown to cause single gene, or
Mendelian, disorders. This usage has been general in clinical
practice.
c Polymorphism: Base changes having no clinical effect. This
usage has also been general in clinical practice.
c Sequence variant: A recently preferred option for any base
change pathogenic at one extreme and with no effect at the
other. Its nature is specified as either causing or not causing
functional or pathological consequences.
c Single nucleotide polymorphism (SNP): Initially coined to
refer to single base changes of little or no functional
consequence, which were sought by researchers for use as
aids in gene mapping, common disease and
pharmacogenomic studies. The term certainly did not include
mutations that cause single gene disorders. It appears that
usage has strayed from that initial definition both from single
nucleotide changes to all sequence variants, and whether or
not they cause single gene disorders.
c General mutation database (GMDB): Sometimes referred to
as central mutation databases, GMDBs strive to collect
mutations in all genes and curate them centrally—for
example, HGMD and OMIM.
c Locus specific database (LSDB): Databases of mutations,
and relevant polymorphisms, in a single gene that are curated
by an expert or experts in that gene. Sometimes the curator
may manage several genes they are researching or
diagnosing.
c Conduit mutation database (CMDB): Displays mutations by
linking to LSDBs or GMDBs—for example, HOWDY.
Table 1 General and locus specific databases studied
Database Address Broad features
Currency of information
(as at 27 October 2006)
HGMD http://www.hgmd.org Collects all mutations in all genes from public sources Quarterly release
OMIM http://www.ncbi.nlm.nih.gov/entrez/query. fcgi?db = OMIM First and interesting mutations with references. Initially
collected mutations
Updated daily
GDB http://www.gdb.org Initially collected mutations 11 August 2005
GeneCards http://www.genecards.org Integrates fragments of information from specialised
databases
9 July 2006
Mutation Discovery http://www.mutationdiscovery.com Initiated to collect DHPLC data 25 August 2003
EBI Mutation Database http://www.ebi.ac.uk Now defunct NA
Howdy http://howdy.jst.go.jp A system to retrieve human genome information from
different public resources
Updated daily
HGVbase http://hgvbase.cgb.ki.se Phenotype/genotype database 23 July 2003
dbSNP http://www.ncbi.nlm.nih.gov/projects/SNP Catalogue of SNPs 18 May 2006
PAH http://www.pahdb.mcgill.ca Locus specific database for PAH 3 August 2006
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The studied databases can be divided into three categories:
1. Those that collect and curate data—OMIM, HGMD and
GDB
2. Those merely acting as a conduit—EBI, GeneCards and
HOWDY
3. Those that both collect and act as a conduit—Mutation
Discovery.
Databases displaying mutations that are clearly currently
active are GeneCards, HOWDY, OMIM and HGMD. Both
OMIM and HGMD are regularly updated, but it is not clear
how often GeneCards and Howdy are updated.
All active databases displaying mutations, except GeneCards,
HOWDY and OMIM, allow submission by users, but no
indication is given as to which mutations have been submitted
or under what criteria or review structure such submissions are
accepted. Some sort of history akin to what is available for
entries in Wikipedia (www.wikipedia.org) would be desirable.
It is difficult to compare the 68 criteria across the seven
databases; suffice to say the quality is patchy with no one
database being judged perfect with a correct/expected entry for
each criterion. Further criteria were assessed and compared
between HGMD and OMIM because they are both highly used
and both collect original data. Because HOWDY is a conduit
database only, OMIM and HGMD received the most critical
appraisal.
Comparison of the main GMDBs containing mutations: OMIM
and HGMD
OMIM contains over 12 000 genes with disease association;
however, HGMD contains only those genes that have variation
data. Here we compare only those genes in OMIM and HGMD
that have mutation data.
The number of mutations listed for each particular gene was
the focus of a detailed study. OMIM (as at 10 October 2006)
had mutation data for 1790 genes (11 392 mutations), where a
mutation is a single base change within an exon, intron or
regulatory region of the gene. In comparison, HGMD (com-
mercial release version 6.3) had mutation data for 2120 genes
(43 627 mutations). Figure 1 details the comparison of entries in
OMIM and HGMD.
Because OMIM only collects the first and notable mutations,
HGMD should always show more mutations per gene in every
gene. However, this is not always the case, with 226 genes in
OMIM having more mutations per gene than the same gene in
HGMD. As expected, 1587 genes in HGMD show more
mutations per gene than the same genes in OMIM. It is
interesting that there are 143 genes with mutations in OMIM
that are not present in HGMD; examples include COL9A1 and
PTCH2 (COL9A1 was added to HGMD after the survey). The
origin of these discrepancies is not clear and indicates one of the
problems for users relying on one or both systems.
Other inconsistencies include missing genes or the complete
absence of mutations for a gene. At the time of analysis 17 genes
with mutations were present in HGMD but the same genes
were absent in OMIM; examples include CYP4F12 and SRPX2.
However, SRPX2 can now be found in OMIM, entered in March
2007. At the mutational level, 457 genes that have mutations
listed in HGMD do not have mutations recorded in OMIM,
even though the gene can be found in OMIM; examples include
ACAD8 and PAX1.
Some of the annotated genes in HGMD have variation data
other than single base mutations. Consistently, where a gene in
HGMD only has variation data that are not simple base
mutations, no single base mutations were noted in OMIM.
Currency of data in HGMD in relation to mutations in the
literature
Mutations published in Human Mutation make up the major
data source for the HGMD database.7 At three times, we
sampled up to three novel mutations in successive earlier issues
of Human Mutation, starting from the issue that was published
on the survey date, and looked to see if they were present in the
public release of the HGMD database (see supplementary table 2
and its summary in supplementary table 3, available online).
At each time point that this survey was conducted, it was
found that a number of mutations reported in the issues of
Human Mutation were missing. For example, two mutations in
the 2002 issues of Human Mutation 19(5) and 19(3) did not
appear in HGMD in the May 2005 survey. It is also interesting
to note that, in some cases, not only was the mutation missing
from the HGMD database, but the gene itself was also missing.
This would seem to indicate an incomplete collection of data
from the published literature.
As HGMD relies on commercial funding to finance its
activities, it has adopted a strategy of charging for access to
the most up-to-date version of its data. For this reason we also
conducted a search for mutations in the HGMD commercial
release, the results of which are shown in supplementary table 3
(available online). Clearly, in January 2007, the commercial
version was 1–2 months behind currency and the public version
around 18 months behind, up from the 14 months in the
Figure 1 Analysis of genes with mutations annotated in Human Gene
Mutation Database (HGMD) and Online Mendelian Inheritance in Man
(OMIM) as of October 2006, where a mutation is a single base pair
change within an exon, intron or regulatory region of a gene. (A) Venn
diagram comparing the number of unique genes in OMIM and HGMD. (B)
Venn diagram comparing the number of unique genes with more
annotated mutations in one database than the other.
Figure 2 The date of publication versus the date of entry into Human
Gene Mutation Database (HGMD) for mutations published in Human
Mutation since May 2000. A mutation is a single base pair change within
an exon, intron or regulatory region of the gene.
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previous surveys. The patchiness of genes and mutations
covered is also evident in the commercial release, so the quality
of the public data is just as good as the commercial release, if
somewhat dated.
Figure 2 illustrates the time taken for a mutation to be
entered into HGMD after publication. Although mutations are
entered continually, this information is only available to users
in bursts upon a new database release. Mutations that appear in
the database before their publication in Human Mutation most
likely represent mutations that have been republished. For
example, a new publication was entered for the mutations
recorded in the gene ATP7B after the LSDB for this gene updated
its source publication.
It is worth noting that it was not always clear if a particular
mutation found in Human Mutation had been included in the
HGMD collection due to name changes in moving from the
published data to HGMD. For example, mutations may have
been reported in Human Mutation with a name based on the
genomic sequence but, due to the naming conventions
employed by HGMD, the identifier was converted to a cDNA
name when included in the database. In other cases, the
mutations were present in the HGMD database, but a journal
other than Human Mutation was cited as the source, possibly
indicating publication by multiple groups.
Search for specific mutations in HOWDY, GeneCards, EBI,
Mutation Discovery and GDB
We searched for the specific mutations PAH p.R158Q and PKD2
p.Q405X, published in Human Mutation in 2000 and 2001,
respectively,20 21 in the various mutation databases. At the time,
none of the five databases showed the p.Q405X mutation.
HGMD, OMIM and PAH LSDB do have an entry for p.R158Q
but cite earlier research articles.22 23 The reference used by the
PAH LSDB23 is an initial report of the allele, but the database
should consider referencing a second paper by the same authors
(Okano et al24) that discusses the precise mutation.
Number of mutations in GMDBs compared with the number in
LSDBs
As expected, the LSDBs have more mutations than HGMD, and
HGMD has more mutations than OMIM. The other four
GMDBs are clearly further behind and dbSNP only links a small
number of its listed variations to OMIM (table 2).
Data presentation for mutations in LSDBs, HGMD and OMIM
Across the range of GMDBs, the method employed to display
the mutation and associated data differs greatly (fig 3). At the
two extremes of this scale are OMIM and HGMD. OMIM lists
variants and their associated information in textual form,
allowing phenotypic effects and discovery information to be
clearly described and easily read. However, the layout prohibits
efficient computational data mining. HGMD, on the other
hand, relies exclusively on tabular layouts, presenting its data in
a series of columns. Extra information is obtained through the
listed references, either to published articles or LSDBs. HGMD is
held in a MySQL database (licence required), which makes the
data easily accessible through simple database queries.
The most notable disadvantage of HGMD is the lack of
adherence to the Human Genome Variation Society (HGVS)
recommended mutation nomenclature (http://www.hgvs.org/
mutnomen/), which perhaps explains some of the problems in
the survey and the extra work required to find particular
mutations in HGMD. Under the HGVS nomenclature it is
possible to name any variant using three frames of reference for
positional number: genomic DNA position, cDNA position and
amino acid position. HGMD only provides the codon number to
position exonic mutations and the IVS numbering system for
intronic mutations.25
Data presentation for OMIM has traditionally been textual
using the Human Genome Variation Society nomenclature.25–27
The PAH LSDB also uses this nomenclature.
DISCUSSION
Databases that summarise information and contain or point to
original or other sources are an essential part of today’s data
driven world. Currency and accuracy is particularly crucial in
the area of human health as there can be life or death issues
involved. Because of the important role that databases of
mutations play in genetic healthcare or research, central
databases containing mutations were reviewed for content. As
‘‘controls’’ two primarily SNP databases and two LSDBs were
also reviewed (see supplementary table 1, available online).
To assess utility against an ‘‘ideal database’’ we chose some of
the relevant characteristics from another review, Claustres et
al,15 and applied these to the 11 databases. The survey was
difficult and perhaps qualitative because only partial replies
could be given in some cases. Nevertheless, some valuable
conclusions can be drawn to provide a perspective for those
dealing with mutations causing single gene disorders.
All 11 databases were given a score by counting the number
of ‘‘yes’’ entries. This clearly can only give rise to a qualitative
figure for comparison because certain characteristics should be
weighted—for example, nomenclature or public availability—
and some boxes contained partial agreement with the question.
Nevertheless, it is interesting that among all the mutation
displaying databases reviewed, a ‘‘gold standard/prototype’’
database—the phenylalanine hydroxylase (PAH) LSDB—comes
out on top, as perhaps expected, and interestingly GeneCards
came out second. However, if mutation content had been
scored and weighted, GeneCards would have scored much
lower. Notionally the ideal general database should apply all the
desirable characteristics of an LSDB to all genes with reported
variants.
With regard to content, for sequence variants that cause
disorders, the most widely used GMDBs are HGMD and
OMIM. All other general databases have insignificant numbers
of mutations in ‘‘all genes’’. The mutation section of EBI, which
employed the SRS system to harvest mutations from LSDBs,
contained some 30 genes, but this section seems to have
disappeared between October 2006 and March 2007. Mutation
Discovery was initiated by Transgenomic Inc as a service and a
portal for those using dHPLC instruments, but was last updated
Table 2 Number of mutations in general mutation databases (GMDBs)
compared with the number in specific locus specific databases (LSDBs)
Database PAH PKD2 AR CFTR
LSDB* 528 308 514 1529
OMIM 59 5 50 136
HGMD 444 44 289 1208
HOWDY 15 0 0 NF
GeneCards 1 0 0 0
Mutation Discovery 2 1 4 0
GDB 0 0 0 13
dbSNP (linked to OMIM) 350 (5) 273 (0) 402 (0) 515 (3)
NF, not found.
*Consulted LSDBs: PAH (http://www.pahdb.mcgill.ca/), PKD2 (http://pkdb.mayo.edu),
AR (http://androgendb.mcgill.ca) and CFTR (http://www.genet.sickkids.on.ca/cftr).
Review
68 J Med Genet 2008;45:65–70. doi:10.1136/jmg.2007.052639
 group.bmj.com on October 27, 2011 - Published by jmg.bmj.comDownloaded from 
in 2003. GDB, initiated as part of the Human Genome Project,
has not been updated since 2005. Although they are not current,
GDB, EBI and Mutation Discovery may still have either useful
software or other information. Only GeneCards, Howdy,
HGMD and OMIM seem to be current and have regular, if
sometimes infrequent, updates. Of the four current databases,
only HGMD and OMIM have useful numbers of mutations.
GeneCards and Howdy seem to be mainly conduit databases—
that is, they rely on links to the other collections of mutations.
Anecdotally, it is well known that LSDBs usually contain more
mutations than the two main GMDBs, HGMD and OMIM, and
this has been confirmed.
Notable are the small numbers of SNPs in dbSNP that have
links to OMIM, indicating that they are variations causing
Mendelian disease. It should be kept in mind that dbSNP and
the other mutation databases contain very different data.
dbSNP aims to capture common allelic variants in the human
population.17 The mutation databases, on the other hand,
contain mutation data for Mendelian disease in specific families
that may be rare. dbSNP is often used by researchers to
determine whether a sequencing variant is in fact a rare
mutation in their families or a harmless common variant found
in the general population. Currently, OMIM has very high
standards as to whether a disease associated SNP is included
into the database. This might explain disease–gene associations
in HGMD that are absent in OMIM. It is likely that as rarer
allelic variants are catalogued by dbSNP and the genetic basis of
complex disease emerges, the overlap between the two types of
databases will increase.
Several observations can be made with regard to the quality
of the data. Firstly, some data are missing from both of the
major GMDBs. It was found that there were 226 genes in
OMIM that had more single base mutations than in HGMD.
This was surprising because HGMD aims to collect all
mutations whereas OMIM addresses only the first and most
interesting ones. Also, there were 143 genes in OMIM with
mutations that were not present in HGMD—for example,
COL9A1 and PTCH2. These observations have no clear
explanation and tend to reduce confidence because one would
expect the two databases to be consistent with each other. Our
study of HGMD found omissions of mutations, and in some
cases, the gene itself, reported in Human Mutation, suggesting
incomplete collection of data was at least part of the problem.
The currency of the available HGMD commercial release is
well ahead of the currency of the public release, with the data
appearing 1–2 months and around 18 months post-publication,
respectively. This is not a problem if users can afford to access
the commercial release. However, public benefit must be
balanced with commercial need. The Protein Data Bank28 allows
researchers to quarantine commercially valuable structures for
up to 12 months before they are released to the public, and
recently the National Institute of Health announced that
scientists contributing data from genome-wide association
studies would be granted data exclusivity for up to 12 months.
Given the fast pace of discovery it would be desirable for the
public version of HGMD to be no further than 12 months
behind the commercial release. This situation was recently
ameliorated by the introduction of a discounted academic
licence fee for HGMD, allowing access to the most recent
version.
One major issue that distinguishes HGMD from the LSDBs is
that it collects only a single instance of any mutation, which is
usually the first published account. Any subsequent published
account of the same mutation is not recorded. However,
different individuals harbouring exactly the same mutation
might not have identical phenotypes. This is especially true of
dominant mutations and mutations causing variable expression.
The archiving of mutation data is a complex and laborious
task but one that has enormous social impact and benefit. The
visionary efforts to set up these databases and the labour of
maintaining them should be applauded. However, efforts to
improve them must continue. This has been difficult from
several perspectives. The exponential growth of data, particu-
larly in the light of recent association studies,29 has been a
problem. With this growth of knowledge our understanding of
the relationship between genotype and phenotype is gradually
changing, bringing new challenges for database design.
In conclusion, this survey has indicated that while the two
major GMDBs are clearly useful and well used, they have some
characteristics that are less than ideal. These are: mutation
nomenclature usage; failure to assimilate all available data; and
lack of important characteristics usually confined to LSDBs.
Some of these adverse characteristics derive from historical and
financial realities and are readily explained, but some, such as
missing genes and mutations, are not. It is unrealistic to expect
curators of large GMDBs to be experts on all genes. Indeed, a
resolution of a meeting in 1994 of some of the world’s
prominent geneticists concluded that mutations in genes were
best curated by experts in each gene.11 We need to ensure that
efforts to curate individual genes are utilised rather than the
Figure 3 Comparison of data presentation techniques across (A) the phenylalanine hydroxylase (PAH) locus specific database, (B) Human Gene
Mutation Database (HGMD), and (C) Online Mendelian Inheritance in Man (OMIM).
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GMDBs trying to collect the data de novo. Ideally a GMDB
would transfer data from existing online LSDBs. This is already
occurring to some extent. However, gene curation is time
consuming and expensive30 and the Human Variome Project31
aims to address these problems. Data in publications and
databases needs to be correct as life and death decisions rest on
them, and this can best be ensured by curators.
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